The Chemours Company
CC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,380 | $1,720 | $2,028 | $2,532 |
| - Cash | $613 | $502 | $464 | $713 |
| + Debt | $255 | $4,407 | $4,381 | $4,355 |
| Enterprise Value | $2,022 | $5,625 | $5,945 | $6,174 |
| Revenue | $1,495 | $1,615 | $1,368 | $1,394 |
| % Growth | -7.4% | 18.1% | -1.9% | – |
| Gross Profit | $235 | $278 | $236 | $273 |
| % Margin | 15.7% | 17.2% | 17.3% | 19.6% |
| EBITDA | $198 | $152 | $154 | $154 |
| % Margin | 13.2% | 9.4% | 11.3% | 11% |
| Net Income | $60 | -$381 | -$4 | -$8 |
| % Margin | 4% | -23.6% | -0.3% | -0.6% |
| EPS Diluted | 0.399 | -2.54 | -0.027 | -0.053 |
| % Growth | 115.7% | -9,413.1% | 50% | – |
| Operating Cash Flow | $146 | $93 | -$112 | $138 |
| Capital Expenditures | -$41 | -$43 | -$84 | -$109 |
| Free Cash Flow | $105 | $50 | -$196 | $29 |